Eurofins Pharma Services newsletter N°1 - February 2012
ARTICLES:
- Eurofins expands global technology portfolio and geographic reach with Lancaster Laboratories
- Eurofins launches new dedicated Global Central Laboratory in India
- Disinfectants used in pharmaceutical facility for sterile production: risk analysis, efficacy requirements and validation procedures
- Impact of the new European Guideline for the bioanalytical method validation
- Dried blood spots reduce cost of drug development
- Coming Events
> Download the pdf version of the newsletter
Subscribe to receive an email with the next newsletter.
